Structure of the Blood–Brain Barrier and Its Role in the Transport of Amino Acids
Open accessAbstract
Brain capillary endothelial cells form the blood-brain barrier (BBB). They are connected by extensive tight junctions, and are polarized into luminal (blood-facing) and abluminal (brain-facing) plasma membrane domains. The polar distribution of transport proteins mediates amino acid (AA) homeostasis in the brain. The existence of two facilitative transporters for neutral amino acids (NAAs) on both membranes provides the brain access to essential AAs. Four Na(+)-dependent transporters of NAA exist in the abluminal membranes of the BBB. Together these systems have the capability to actively transfer every naturally occurring NAA from the extracellular fluid (ECF) to endothelial cells and from there into circulation. The presence of Na(+)-dependent carriers on the abluminal membrane provides a mechanism by which NAA concentrations in the ECF of brain are maintained at approximately 10% those of the plasma. Also present on the abluminal membrane are at least three Na(+)-dependent systems transporting acidic AAs (EAAT) and a Na(+)-dependent system transporting glutamine (N). Facilitative carriers for glutamine and glutamate are found only in the luminal membrane of the BBB. This organization promotes the net removal of acidic- and nitrogen-rich AAs from the brain and accounts for the low level of glutamate penetration into the central nervous system. The presence of a gamma-glutamyl cycle at the luminal membrane and Na(+)-dependent AA transporters at the abluminal membrane may ser…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Sodium-dependent amino acid transporters ASCT1/2 and GLYT1 at the abluminal membrane remove nonessential amino acids alanine, serine, and cysteine, and glycine, respectively, from brain to blood.
“Sodium-dependent AA transporters ASCT1/2 and GLYT1 at the abluminal membrane remove nonessential AA alanine, serine and cysteine, and glycine, respectively, from brainto-blood (240).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [240]
Glutamine levels are higher in brain interstitial fluid.
“Glutamine levels are higher in brain ISF (240).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [240]
Cites
Electrical resistance of brain microvascular endothelium
Crone, C., & Olesen, S. P. (1982) · Brain Research · doi:10.1016/0006-8993(82)91227-6 · Cited by 491 · see citing works
Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal
Lee, W.-J., Hawkins, R. A., Viña, J. R., & Peterson, D. R. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.4.c1101 · Cited by 191 · see citing works
Self-citationO'Kane, R. L., & Hawkins, R. A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00193.2003 · Cited by 105 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · see citing works
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works
Supply and demand in cerebral energy metabolism: the role of nutrient transporters
Simpson, I. A., Carruthers, A., & Vannucci, S. J. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600521 · Cited by 812 · see citing works
Self-citationPotential of solid lipid nanoparticles in brain targeting.
Kaur, I. P., Bhandari, R., Bhandari, S., & Kakkar, V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.018 · Cited by 615 · see citing works
Mutations in <i>BCKD-kinase</i> Lead to a Potentially Treatable Form of Autism with Epilepsy
Novarino, G., El-Fishawy, P., Kayserili, H., Meguid, N. A., Scott, E. M., Schroth, J., Silhavy, J. L., Kara, M., Khalil, R. O., Ben-Omran, T., et al. (2012) · Science · doi:10.1126/science.1224631 · Cited by 320 · see citing works
Development and Function of the Blood-Brain Barrier in the Context of Metabolic Control
Haddad-Tóvolli, R., Dragano, N. R. V., Ramalho, A. F. S., & Velloso, L. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00224 · Cited by 226 · see citing works
Transport of Amino Acids Across the Blood-Brain Barrier
Zaragozá, R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00973 · Cited by 202 · see citing works
Nanoscale drug delivery systems and the blood&ndash;brain barrier
Khalin, I., Alyautdin, R., Ismail, N. M., Haron, M. H., & Kuznetsov, D. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s52236 · Cited by 204 · see citing works
The ketogenic diet and brain metabolism of amino acids: Relationship to the anticonvulsant effect
Yudkoff, M., Daikhin, Y., Melø, T. M., Nissim, I., Sonnewald, U., & Nissim, I. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093722 · Cited by 202 · see citing works
Alteration of Plasma Glutamate and Glutamine Levels in Children with High-Functioning Autism
Shimmura, C., Suda, S., Tsuchiya, K. J., Hashimoto, K., Ohno, K., Matsuzaki, H., Iwata, K., Matsumoto, K., Wakuda, T., Kameno, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025340 · Cited by 189 · see citing works
Amino acid catabolism in Alzheimer’s disease brain: Friend or foe?
Griffin, J. W. D., & Bradshaw, P. C. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5472792 · Cited by 185 · see citing works
Pericytes impair capillary blood flow and motor function after chronic spinal cord injury
Li, Y., Lucas-Osma, A. M., Black, S., Bandet, M. V., Stephens, M. J., Vavrek, R., Sanelli, L., Fenrich, K. K., Di Narzo, A. F., Dracheva, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4331 · Cited by 164 · see citing works
Homeostatic regulation of protein intake: in search of a mechanism
Morrison, C. D., Reed, S. D., & Henagan, T. M. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00609.2011 · Cited by 99 · see citing works
Neural and metabolic regulation of macronutrient intake and selection
Berthoud, H.-R., Münzberg, H., Richards, B. K., & Morrison, C. D. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112000559 · Cited by 87 · see citing works
Molecular and cellular immune mediators of neuroprotection
Turrin, N. P., & Rivest, S. (2006) · Molecular Neurobiology · doi:10.1385/mn:34:3:221 · Cited by 85 · see citing works
Blum, K. (2013) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000139 · Cited by 73 · see citing works
Discovery of NV-5138, the first selective Brain mTORC1 activator
Sengupta, S., Giaime, E., Narayan, S., Hahm, S., Howell, J., O’Neill, D., Vlasuk, G. P., & Saiah, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-40693-5 · Cited by 72 · see citing works
Del Amo, L., Cano, A., Ettcheto, M., Souto, E. B., Espina, M., Camins, A., García, M. L., & Sánchez-López, E. (2021) · Applied Sciences · doi:10.3390/app11094305 · Cited by 67 · see citing works
Amino Acids, Peptides, and Proteins
Dietzen, D. J. (2018) · Principles and Applications of Molecular Diagnostics · doi:10.1016/b978-0-12-816061-9.00013-8 · Cited by 82 · see citing works
Elliott, J. E., Keil, A. T., Mithani, S., Gill, J. M., O’Neil, M. E., Cohen, A. S., & Lim, M. M. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.854874 · Cited by 22 · see citing works
- Authors
- Hawkins, R. A., O’Kane, R. L., Simpson, I. A., & Viña, J. R.
- Affiliations
- Universitat de València (ES)
- LaGuardia Community College (US)
- Pennsylvania State University (US)
- Corresponding author
- Hawkins, Richard A
- Venue
- The Journal of Nutrition
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 136
- Issue
- 1
- Pages
- 218S-226S
- ISSN
- 0022-3166 (ISSN-L)
- OpenAlex
- W2129219544
- Cited by
- 453
- References
- 3
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 16 · 2023: 21 · 2022: 23 · 2021: 28 · 2020: 32 · 2019: 26 · 2018: 26 · 2017: 28 · 2016: 23 · 2015: 31 · 2014: 21 · 2013: 18 · 2012: 27
- FWCI
- 11.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns031017-03)
- Instituto de Salud Carlos III
- National Institute of Neurological Disorders and Stroke (NS-31017, R01NS041405, NS-041405)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- blood-brain barrier, amino acid transport, brain microvascular endothelial cells, tight junctions, endothelial cell polarity, neutral amino acid transporter, glutamate uptake, glutamine transport, glutamine synthetase, gamma-glutamyl cycle, pyroglutamic acid, amino acid homeostasis, essential amino acids
- MeSH terms
- Amino Acids, Ammonia, Animals, Biological Transport, Blood-Brain Barrier, gamma-Glutamyltransferase, Glutamine, Humans, Pyrrolidonecarboxylic Acid, Sodium, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review